Importantly, before anti-IL-18 therapeutics are considered for treating severe asthma, further studies are needed to characterize the in vivo phenotype and effect of IL-18/IL-18R signaling on ILC2 activation in asthma models. The gene discussed is IL18; the disease is asthma.